Evidence map›Paper›PMID 30409123›Full record

ArticleBMC gastroenterology2018

Evaluating gut microbiota profiles from archived fecal samples.

Trine B Rounge, Roger Meisal, Jan Inge Nordby, Ole Herman Ambur, Thomas de Lange, Geir Hoff

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Comparison of Fecal Sample Collection Methods for Microbial Analysis Embedded within Colorectal Cancer Screening Programs.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Trine B RoungeDepartment of Research, Cancer Registry of Norway, Oslo, Norway. trine.rounge@kreftregisteret.no.ORCID http://orcid.org/0000-0003-2677-2722
Roger MeisalDepartment of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.
Jan Inge NordbyDepartment of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Ole Herman AmburDepartment of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.
Thomas de LangeSection for Bowel Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Geir HoffSection for Bowel Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Akershus University Hospital · NOCancer Registry of Norway · NOOsloMet – Oslo Metropolitan University · NOOslo University Hospital · NOTelemark Hospital · NOUniversity of Oslo · NO

Funding

Cancer Registry of Norway Funds -
6 · The paper itself

Abstract

backgroundAssociations between colorectal cancer and microbiota have been identified. Archived fecal samples might be valuable sample sources for investigating causality in carcinogenesis and biomarkers discovery due to the potential of performing longitudinal studies. However, the quality, quantity and stability of the gut microbiota in these fecal samples must be assessed prior to such studies. We evaluated i) cross-contamination during analysis for fecal blood and ii) evaporation in stored perforated fecal immunochemical tests (iFOBT) samples, iii) temperature stability as well as iv) comparison of the gut microbiota diversity and composition in archived, iFOBT and fresh fecal samples in order to assess feasibility of large scale microbiota studies.

methodsThe microbiota profiles were obtained by sequencing the V3-V4 region of 16S rDNA gene.

resultsThe iFOBT does not introduce any cross-sample contamination detectable by qPCR. Neither could we detect evaporation during freeze-thaw cycle of perforated iFOBT samples. Our results confirm room temperature stability of the gut microbiome. Diverse microbial profiles were achieved in 100% of fresh, 81% of long-term archived and 96% of iFOBT samples. Microbial diversity and composition were comparable between fresh and iFOBT samples, however, diversity differed significantly between long-term archived, fresh and iFOBT samples.

conclusionOur data showed that it is feasible to exploit archived fecal sample sets originally collected for testing of fecal blood. The advantages of using these sample sets for microbial biomarker discovery and longitudinal observational studies are the availability of high-quality diagnostic and follow-up data. However, care must be taken when microbiota are profiled in long-term archived fecal samples.

Indexed as

DNA ContaminationOccult BloodAgedBiomarkers, TumorColorectal NeoplasmsFecesGastrointestinal MicrobiomeHumansImmunochemistryMiddle AgedPolymerase Chain ReactionRNA, Ribosomal, 16SSequence Analysis, DNASpecimen HandlingTemperatureTime FactorsBiomarkers, TumorRNA, Ribosomal, 16SArchived samplesDiversityFecal immunochemical testsFecal samplesMicrobiotaStorage

Identifiers

PMID30409123
PMCPMC6225565
OpenAlexW2899926693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.